Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 501

1.

Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?

Feng W, Hua K, Malpica A, Zhou X, Baak JP.

Int J Gynecol Cancer. 2013 Mar;23(3):488-93. doi: 10.1097/IGC.0b013e318247aa14.

PMID:
23435438
2.

[Clinical review of 97 patients with endometrial stromal sarcoma].

Li N, Wu LY, Zhang HT, An JS, Li XG, Ma SK.

Zhonghua Fu Chan Ke Za Zhi. 2008 Feb;43(2):115-9. Chinese.

PMID:
18683750
3.

Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma.

Feng W, Hua K, Gudlaugsson E, Yu Y, Zhou X, Baak JP.

Histopathology. 2013 Apr;62(5):675-87. doi: 10.1111/j.1365-2559.2011.04115.x. Epub 2013 Feb 21.

PMID:
23425310
4.

Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.

Bodner K, Bodner-Adler B, Obermair A, Windbichler G, Petru E, Mayerhofer S, Czerwenka K, Leodolter S, Kainz C, Mayerhofer K.

Gynecol Oncol. 2001 May;81(2):160-5.

PMID:
11330943
5.

Surgery and adjuvant radiation therapy of endometrial stromal sarcoma.

Weitmann HD, Kucera H, Knocke TH, Pötter R.

Wien Klin Wochenschr. 2002 Jan 15;114(1-2):44-9.

PMID:
12407935
6.

Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.

Kuku S, Williams M, McCormack M.

Int J Gynecol Cancer. 2013 Jul;23(6):1056-64. doi: 10.1097/IGC.0b013e3182978328.

PMID:
23765205
7.

Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study.

Schick U, Bolukbasi Y, Thariat J, Abdah-Bortnyak R, Kuten A, Igdem S, Caglar H, Ozsaran Z, Lössl K, Schleicher U, Zwahlen D, Villette S, Vees H.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):e757-63. doi: 10.1016/j.ijrobp.2011.11.005. Epub 2012 Jan 31.

PMID:
22300565
8.

Does radiotherapy or lymphadenectomy improve survival in endometrial stromal sarcoma?

Barney B, Tward JD, Skidmore T, Gaffney DK.

Int J Gynecol Cancer. 2009 Oct;19(7):1232-8. doi: 10.1111/IGC.0b013e3181b33c9a.

PMID:
19823060
9.

Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma.

Amant F, De Knijf A, Van Calster B, Leunen K, Neven P, Berteloot P, Vergote I, Van Huffel S, Moerman P.

Br J Cancer. 2007 Nov 5;97(9):1194-9. Epub 2007 Sep 25.

10.

Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.

Hiura M, Nogawa T, Matsumoto T, Yokoyama T, Shiroyama Y, Wroblewski J.

Int J Gynecol Cancer. 2010 Aug;20(6):1000-5. doi: 10.1111/IGC.0b013e3181d80aff.

PMID:
20683408
11.

Prognostic factors, treatment and outcome in a Turkish population with endometrial stromal sarcoma.

Donertas A, Nayki U, Nayki C, Ulug P, Gultekin E, Yildirim Y.

Asian Pac J Cancer Prev. 2015;16(3):881-7.

12.

Clinical characteristics, pathological reevaluation, surgical management and adjuvant therapy of patients with endometrial stromal tumors.

Rothmund R, Hartkopf A, Joachim C, Walter CB, Wallwiener M, Kraemer B, Brucker SY, Staebler A, Taran FA.

Arch Gynecol Obstet. 2014 Dec;290(6):1195-200. doi: 10.1007/s00404-014-3320-7. Epub 2014 Jul 1.

PMID:
24981048
13.

Endometrial stromal sarcoma: analysis of treatment failures and survival.

Gadducci A, Sartori E, Landoni F, Zola P, Maggino T, Urgesi A, Lissoni A, Losa G, Fanucchi A.

Gynecol Oncol. 1996 Nov;63(2):247-53.

PMID:
8910635
14.

Endometrial stromal sarcoma: prognostic factors and impact of adjuvant therapy in early stages.

Tanz R, Mahfoud T, Bazine A, Aassab R, Benjaafar N, El Khalil El Gueddari B, Ichou M, Errihani H.

Hematol Oncol Stem Cell Ther. 2012;5(1):31-5. doi: 10.5144/1658-3876.2012.31.

15.

[Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].

Tu H, Huang H, Huang QD, Li Z, Feng YL, Liu JH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Dec;47(12):928-33. Chinese.

PMID:
23324194
16.

Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.

Geller MA, Argenta P, Bradley W, Dusenbery KE, Brooker D, Downs LS Jr, Judson PL, Carson LF, Boente MP.

Gynecol Oncol. 2004 Dec;95(3):632-6.

PMID:
15581975
17.

Impact of adjuvant treatment modalities on the management of patients with stages I-II endometrial stromal sarcoma.

Malouf GG, Duclos J, Rey A, Duvillard P, Lazar V, Haie-Meder C, Balleyguier C, Morice P, Lhommé C, Pautier P.

Ann Oncol. 2010 Oct;21(10):2102-6. doi: 10.1093/annonc/mdq064. Epub 2010 Mar 19.

PMID:
20305035
18.

[Synchronous primary cancers of the endometrium and ovary: review of 43 cases].

Ma SK, Zhang HT, Sun YC, Wu LY.

Zhonghua Zhong Liu Za Zhi. 2008 Sep;30(9):690-4. Chinese.

PMID:
19173912
19.

Ovarian preservation in stage I low-grade endometrial stromal sarcomas.

Li AJ, Giuntoli RL 2nd, Drake R, Byun SY, Rojas F, Barbuto D, Klipfel N, Edmonds P, Miller DS, Karlan BY.

Obstet Gynecol. 2005 Dec;106(6):1304-8.

PMID:
16319256
20.

Ovary and uterus-sparing procedures for low-grade endometrial stromal sarcoma: a retrospective study of 153 cases.

Bai H, Yang J, Cao D, Huang H, Xiang Y, Wu M, Cui Q, Chen J, Lang J, Shen K.

Gynecol Oncol. 2014 Mar;132(3):654-60. doi: 10.1016/j.ygyno.2013.12.032. Epub 2014 Jan 9.

PMID:
24412112

Supplemental Content

Support Center